Fizogen Precision Technologies, Inc. issues a Nationwide Recall of OFF CYCLE II HARDCORE, a product marketed as a Dietary Supplement
Free Dangerous Dietary Supplement Recall Case Evaluation: If you or a loved one has experienced any adverse side effects after taking any of the drugs included in this recall, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
September 17, 2010 - This week, Fizogen Precision Technologies announced that it is issuing a nationwide recall of all Lot Codes of the company's dietary supplement product sold under the name Off Cycle II Hardcore which contains 3,17-keto-etiochol-triene (a synonym for ATD an aromatase inhibitor).
The FDA has requested that Fizogen inform consumers that adverse events associated with the use of Aromatase Inhibitors could include the following:
- decreased rate of bone maturation and growth
- decreased sperm production
- aggressive behavior
- adrenal insufficiency
- kidney failure
- liver dysfunction
Consumers with liver, kidney, adrenal, or prostate abnormalities are at higher risk for developing adverse events. The FDA concludes that products containing aromatase inhibitors have a reasonable probability of resulting in permanent impairment of a body structure or function in at risk consumers.
Off Cycle II Hardcore had been sold nationwide but was discontinued by Fizogen in July of 2009. The product was sold in bottles containing ninety (90) capsules and was manufactured exclusively for Fizogen Precision Technologies. Although the product was discontinued over a year ago, it has come to the attention of Fizogen that some online retailers may still have remaining inventory that they are offering for sale.
Do I have a Fizogen Dietary Supplement Recall Lawsuit?
The Defective Drug & Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in dangerous dietary supplement recall lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.